drugset / Trial / NCT07391618

Clinical Study on the First-line Treatment of Advanced Colorectal Cancer With Simultaneous Infusion of Levozolinate for Injection and 5-FU

NCT07391618 ↗

Phase 2 Recruiting 583 enrolled Chinese PLA General Hospital
Non-randomizedParallel-groupOpen-labelTreatment

Summary

Phase II study of simultaneous infusion of levozolinate for injection and 5-FU as first-line treatment for advanced colorectal cancer

Timeline

Start
2025-05-15
Primary completion
2028-12
Completion
2029-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Irinotecan Small molecule 180 mg/m2 Intravenous
Subject Levofolic acid Unknown 200 mg/m2 —
Subject Oxaliplatin Small molecule 85 mg/m2 Intravenous
Subject fluorouracil Small molecule 400 mg/m2 —
Subject fluorouracil Small molecule 2400 mg/m2 —

Indications